The deal size was increased to $125M from $100M and priced below last closing price of $9.05. Goldman Sachs, Leerink and Evercore ISI are acting as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ETNB:
- 89bio announces $100M common stock offering
- 89bio reports Q3 EPS ($1.39), consensus (64c)
- Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
- 89bio appoints Teresa Perney as chief regulatory and quality officer
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
